Type 2 Diabetes

T2D Patient-Reported Outcomes Improved After Switching From Dulaglutide to Tirzepatide

Physician’s Briefing

T2D Patient-Reported Outcomes Improved After Switching From Dulaglutide to Tirzepatide

01 Apr 2026

2 min read

Major Cardiovascular Event Risk Increased With Discontinuation of GLP-1 RAs in T2D

Physician’s Briefing

Major Cardiovascular Event Risk Increased With Discontinuation of GLP-1 RAs in T2D

31 Mar 2026

2 min read

Childhood Obesity Tied to Cardiometabolic Disease at Age 30 Years

Physician’s Briefing

Childhood Obesity Tied to Cardiometabolic Disease at Age 30 Years

30 Mar 2026

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com